Lv01
0 积分 2024-02-20 加入
A phase I/II study of ARO-HSD, an RNA interference therapeutic, for the treatment of non-alcoholic steatohepatitis
8小时前
待确认
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
1个月前
已完结
Disparities in screening and risk stratification for hispanic adults with metabolic dysfunction-associated steatotic liver disease
1个月前
已完结
Prevalence of Fatty Liver Disease and Hepatic Iron Overload in a Northeastern German Population by Using Quantitative MR Imaging
2个月前
已完结
Impact of Type 2 Diabetes on the Accuracy of Noninvasive Tests of Liver Fibrosis With Resulting Clinical Implications
2个月前
已完结
Single cell landscape of functionally cured chronic hepatitis B patients reveals activation of innate and altered CD4-CTL-driven adaptive immunity
6个月前
已完结
Artificial intelligence-assisted digital pathology for non-alcoholic steatohepatitis: current status and future directions
7个月前
已完结
Unveiling the promise of pyrimidine-modified CDK inhibitors in cancer treatment
10个月前
已完结
Revolutionizing Anti-HER2 Therapies for Extrahepatic Cholangiocarcinoma and Gallbladder Cancer: Current Advancements and Future Perspectives
1年前
已完结
Exploration of the key genes involved in Non-alcoholic fatty liver disease and possible microRNA therapeutic targets
1年前
已完结
皖公网安备34019202002308
